Related Experiment Videos
Anonymous cocaine screening in a private obstetric population
Obstetrics and Gynecology
|March 1, 1993
Summary
Cocaine use prevalence in private obstetric patients is low (0.35%). Universal urine screening for cocaine is not cost-effective; targeted screening for high-risk individuals is recommended.
Area of Science:
- Obstetrics and Gynecology
- Clinical Toxicology
- Public Health
Background:
- Substance abuse during pregnancy poses significant risks to both mother and child.
- Understanding the prevalence of specific drug use, like cocaine, is crucial for targeted interventions.
- Private obstetric settings may have different patient demographics and substance use patterns compared to public healthcare.
Purpose of the Study:
- To determine the prevalence of cocaine use among patients receiving private obstetric care.
- To assess cocaine use at two key points: during routine prenatal care and upon admission for delivery.
Main Methods:
- Anonymous urine samples were collected from 1425 pregnant patients across six private hospitals and four private physician offices.
- Samples were analyzed for the presence of cocaine metabolites.
Main Results:
- A total of five out of 1425 (0.35%) urine specimens tested positive for cocaine metabolites.
- Prevalence was 0.54% in hospital samples and 0.23% in private office samples during prenatal care.
Conclusions:
- Universal cocaine screening in this private obstetric population is not considered cost-effective.
- Healthcare providers should prioritize patient history-taking regarding substance abuse.
- Screening efforts should focus on identifying and managing high-risk individuals for substance use.